Recor Medical wins first FDA nod for renal denervation. Is Medtronic next? - podcast episode cover

Recor Medical wins first FDA nod for renal denervation. Is Medtronic next?

Nov 09, 202311 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, November 9, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Xenter this week unveiled its new dual-sensor guidewire for TAVR procedures. Fast Five hosts Sean Whooley and Danielle Kirsh talk about the technology and what its designed to do. An independent committee apart of NICE has recommended automated insulin delivery technology rollouts in the U.K. Hear what the committee recommended exactly and what major diabetes companies think. GE HealthCare and Masimo are collaborating on patient monitoring technology. Whooley explains the goal of the partnership and how they plan to achieve that goal.  Abbott has launched in the first procedures its dual-chamber pacemaker in the U.S. Find out what the technology does and what doctors think about it.  Recor Medical won the first FDA nod for its renal denervation technology to treat hypertension. Hear more about what the technology does and if Medtronic is next for approval.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Recor Medical wins first FDA nod for renal denervation. Is Medtronic next? | Fast Five Medtech News Podcast - Listen or read transcript on Metacast